Clinical Trial

Alert Burden When Monitoring Patients at Home

Study acronym: WARD-HOME I
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this observational study is to evaluate the burden and clinical relevance of vital sign alerts during home monitoring in recently discharged medical patients. The primary outcome is the total number of vital sign alerts per patient per day. Secondary outcomes include the number of alerts per specific vital sign parameter, the frequency of alerts during daytime versus evening and nighttime, and the peak alert time during the day. We will compare alert data without filtering to data processed with AI-driven filtering methods to assess if these filters reduce the number of non-actionable alerts while maintaining clinical relevance. Participants will be equipped with wearable devices to continuously monitor heart rate, respiratory rate, blood pressure, and oxygen saturation during the first days after hospital discharge. Vital signs will be transmitted remotely, and alerts will be generated based on predefined thresholds.
Trial Details
NCT Number NCT07096648
Lead Sponsor Bispebjerg Hospital
Conditions Continuous Monitoring, Vital Signs Monitoring, Hospital at Home, Remote Monitoring
Enrollment 110 participants
Start Date 2025-06-16
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-31